AstraZeneca (AZN) News Today $74.42 -0.58 (-0.77%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$74.64 +0.22 (+0.30%) As of 06/13/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Ritholtz Wealth Management Acquires 7,101 Shares of AstraZeneca PLC (NASDAQ:AZN)Ritholtz Wealth Management grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 10.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 75,471 shares of the company's stock after purchJune 15 at 6:57 AM | marketbeat.comNorthCrest Asset Manangement LLC Has $1.40 Million Holdings in AstraZeneca PLC (NASDAQ:AZN)NorthCrest Asset Manangement LLC lessened its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 18.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 19,087 shares of the company's stoJune 15 at 4:49 AM | marketbeat.comYousif Capital Management LLC Sells 4,845 Shares of AstraZeneca PLC (NASDAQ:AZN)Yousif Capital Management LLC trimmed its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 13.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,998 shares of the company's stock after selling 4,845 shares during theJune 15 at 3:56 AM | marketbeat.comNew England Research & Management Inc. Boosts Position in AstraZeneca PLC (NASDAQ:AZN)New England Research & Management Inc. lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 159.3% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 15,950 shares of the company's stock aftJune 14 at 6:28 AM | marketbeat.comNew Century Financial Group LLC Reduces Stake in AstraZeneca PLC (NASDAQ:AZN)New Century Financial Group LLC reduced its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 75.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,846 shares of the company's stock after sellinJune 14 at 6:11 AM | marketbeat.comElevation Point Wealth Partners LLC Boosts Holdings in AstraZeneca PLC (NASDAQ:AZN)Elevation Point Wealth Partners LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 23.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,075 shares of the company's stock afJune 14 at 5:53 AM | marketbeat.comAstraZeneca Inks $5.3B Deal With CSPC Pharma For Developing New Oral Drug Candidate, But Retail’s In No Mood To CheerJune 13 at 11:51 AM | msn.comStanley Laman Group Ltd. Purchases 9,614 Shares of AstraZeneca PLC (NASDAQ:AZN)Stanley Laman Group Ltd. increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.5% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 58,849 shares of the company's stock after buying an additional 9,614 sharesJune 13 at 8:40 AM | marketbeat.comAstraZeneca Teams Up With CSPC Pharmaceuticals With Deal Valued at Up to $5.33 BillionJune 13 at 5:29 AM | wsj.comAstraZeneca agrees to research deal worth up to $5.22 billion with CSPCJune 13 at 4:40 AM | reuters.comAssenagon Asset Management S.A. Sells 74,715 Shares of AstraZeneca PLC (NASDAQ:AZN)Assenagon Asset Management S.A. lowered its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.8% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 774,673 shares of the company's stock after selling 74,715 shares during the period. Assenagon AJune 12 at 5:58 AM | marketbeat.comI attended the world's biggest cancer conference. Doctors gave standing ovations to 2 major breakthroughs.June 11, 2025 | msn.comOak Family Advisors LLC Has $13.43 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)Oak Family Advisors LLC cut its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.5% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 182,742 shares of the company's stock after selling 16,961 shares during the quarter. AstrJune 10, 2025 | marketbeat.comWesbanco Bank Inc. Acquires 5,455 Shares of AstraZeneca PLC (NASDAQ:AZN)Wesbanco Bank Inc. boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 5.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 110,577 shares of the company's stock after purchasing an additionalJune 9, 2025 | marketbeat.comPark Avenue Securities LLC Has $6.54 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Park Avenue Securities LLC increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 15.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 88,980 shares of the company's stock after acJune 9, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Professional Advisory Services Inc.Professional Advisory Services Inc. lessened its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 305,433 shares of the company's stock after selling 27,512June 8, 2025 | marketbeat.comNBC Securities Inc. Purchases 3,837 Shares of AstraZeneca PLC (NASDAQ:AZN)NBC Securities Inc. increased its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 95,925.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,841 shares of the company's stock after purchasing an additiJune 8, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Procyon Advisors LLCProcyon Advisors LLC boosted its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 12.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,854 shares of the company's stock after buying an additioJune 7, 2025 | marketbeat.comMerit Financial Group LLC Acquires 14,743 Shares of AstraZeneca PLC (NASDAQ:AZN)Merit Financial Group LLC boosted its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 166.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 23,583 shares of the company's stock after purchasing an additional 14,743 shares during the perioJune 7, 2025 | marketbeat.comBreakwater Capital Group Takes Position in AstraZeneca PLC (NASDAQ:AZN)Breakwater Capital Group acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 5,837 shares of the company's stock, valued at approximately $429,000June 6, 2025 | marketbeat.comFermata Advisors LLC Purchases New Position in AstraZeneca PLC (NASDAQ:AZN)Fermata Advisors LLC purchased a new stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 3,986 shares of the company's stock, valued at approximately $293,0June 6, 2025 | marketbeat.comChesley Taft & Associates LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)Chesley Taft & Associates LLC raised its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3,779.7% during the first quarter, according to its most recent filing with the SEC. The firm owned 131,910 shares of the company's stock after purchasing an additional 128,510 shares duringJune 5, 2025 | marketbeat.comAstraZeneca rallies Wednesday, outperforms marketJune 4, 2025 | marketwatch.com74,997 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Nixon Peabody Trust Co.Nixon Peabody Trust Co. acquired a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 74,997 shares of the company's stock, valued at approxJune 4, 2025 | marketbeat.comGAMMA Investing LLC Buys 573,535 Shares of AstraZeneca PLC (NASDAQ:AZN)GAMMA Investing LLC grew its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 10,431.7% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 579,033 shares of the company's stock after purchasing an additional 573,535 sharesJune 4, 2025 | marketbeat.comAstraZeneca (LSE:AZN) Reports Positive Trial Results For ENHERTU® In Breast Cancer TreatmentJune 3, 2025 | finance.yahoo.comHealthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCOJune 3, 2025 | cnbc.comAstraZeneca Highlights Significant Gains Across Three Major Cancer Trials At ASCOJune 2, 2025 | finance.yahoo.comHow AstraZeneca Is Playing Its Cancer Cards To Become An $80 Billion PharmaJune 2, 2025 | investors.comBlood test-guided treatment with AstraZeneca pill cuts breast cancer progression riskJune 1, 2025 | msn.comDATROWAY® Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung CancerJune 1, 2025 | finance.yahoo.comBlood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study findsJune 1, 2025 | reuters.comCamizestrant reduced the risk of disease progression or death by 56% in patients with advanced HR-positive breast cancer with an emergent ESR1 tumor mutation in SERENA-6 Phase III trialJune 1, 2025 | businesswire.comAstraZeneca PLC (NASDAQ:AZN) Position Increased by Wealth Enhancement Advisory Services LLCWealth Enhancement Advisory Services LLC increased its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 59.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 306,043 shares of the company's stock afterJune 1, 2025 | marketbeat.comToronto Dominion Bank Acquires 9,151 Shares of AstraZeneca PLC (NASDAQ:AZN)Toronto Dominion Bank grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 51.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 27,080 shares of the company's stock after purchasing an additional 9,151 shares during thJune 1, 2025 | marketbeat.com183,548 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 183,548 shares of the comJune 1, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Short Interest UpdateAstraZeneca PLC (NASDAQ:AZN - Get Free Report) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 7,340,000 shares, a growth of 52.3% from the April 30th total of 4,820,000 shares. Currently, 0.2% of the company's shares are sold short. Based on an average trading volume of 5,990,000 shares, the short-interest ratio is presently 1.2 days.June 1, 2025 | marketbeat.comPfizer-Arvinas breast cancer drug tops AstraZeneca's in delaying progressionMay 31, 2025 | reuters.comVersant Capital Management Inc Buys 8,562 Shares of AstraZeneca PLC (NASDAQ:AZN)Versant Capital Management Inc grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1,166.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,296 shares of the company's stock after purchasing anMay 31, 2025 | marketbeat.com111 Capital Purchases New Stake in AstraZeneca PLC (NASDAQ:AZN)111 Capital acquired a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 4,564 shares of the company's stock, valued at approximatelyMay 31, 2025 | marketbeat.comGTS Securities LLC Sells 41,000 Shares of AstraZeneca PLC (NASDAQ:AZN)GTS Securities LLC lessened its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 91.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 3,976 shares of the company's stock after selling 41,000 shares during the period. GTS Securities LLC's holdingMay 31, 2025 | marketbeat.comDanaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine TestsMay 31, 2025 | finance.yahoo.comBoston Common Asset Management LLC Has $5.27 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Boston Common Asset Management LLC grew its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 30.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 71,718 shares of the company's stock after purchasing an adMay 30, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Position Cut by Park National Corp OHPark National Corp OH cut its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 4.2% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 147,725 shares of the company's stock after selling 6,4May 30, 2025 | marketbeat.comDanaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine TestsMay 30, 2025 | insidermonkey.comGuggenheim Keeps Their Buy Rating on AstraZeneca (AZN)May 29, 2025 | theglobeandmail.comDanaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision MedicineMay 29, 2025 | prnewswire.comNorthstar Financial Companies Inc. Buys Shares of 4,226 AstraZeneca PLC (NASDAQ:AZN)Northstar Financial Companies Inc. purchased a new position in AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,226 shares of the company's stock, valuedMay 29, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Integrated Advisors Network LLCIntegrated Advisors Network LLC reduced its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 85.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,447 shares of the company's stock after selling 37,163 shares dMay 29, 2025 | marketbeat.com8,804 Shares in AstraZeneca PLC (NASDAQ:AZN) Acquired by Brucke Financial Inc.Brucke Financial Inc. purchased a new position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 8,804 shares of the company's stock, valued at approximately $623,May 28, 2025 | marketbeat.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼1.120.89▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼1625▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenx News Beigene News BioNTech News Teva Pharmaceutical Industries News Summit Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AZN Stock Free AZN Stock Alerts